PriceTargets.com logo

Glanbia - GLAPF Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $15.60
  • Forecasted Upside: 7.59%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$14.50 As of 03/24/2023 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for GLAPF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Glanbia Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GLAPF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GLAPF

Analyst Price Target is $15.60
▲ +7.59% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Glanbia in the last 3 months. The average price target is $15.60, with a high forecast of $17.20 and a low forecast of $14.00. The average price target represents a 7.59% upside from the last price of $14.50.

This chart shows the closing price for GLAPF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 2 investment analysts is to hold stock in Glanbia. This rating has held steady since October 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/17/2023Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral
1/6/2023Morgan StanleyInitiated CoverageEqual Weight
8/23/2022BarclaysBoost Target€16.50 ➝ €17.20
7/19/2022Berenberg BankLower Target€15.00 ➝ €14.00
4/14/2022Berenberg BankLower Target€16.00 ➝ €14.50
11/12/2021Berenberg BankReiterated RatingBuy
10/8/2021Kepler Capital MarketsDowngradeHold$14.30
8/17/2021BarclaysReiterated RatingOverweight
8/16/2021Berenberg BankReiterated RatingBuy
7/30/2021Kepler Capital MarketsDowngradeHold$11.50
5/10/2021Credit Suisse GroupReiterated RatingOutperform
5/10/2021Berenberg BankReiterated RatingBuy
3/26/2021Kepler Capital MarketsReiterated RatingHold
2/26/2021BarclaysReiterated RatingOverweight
2/26/2021Berenberg BankReiterated RatingBuy
2/12/2021Kepler Capital MarketsDowngradeHold
1/28/2021Kepler Capital MarketsDowngradeBuy ➝ Hold
12/11/2020Kepler Capital MarketsReiterated RatingBuy
10/18/2020Kepler Capital MarketsReiterated RatingBuy
9/1/2020Credit Suisse GroupInitiated CoverageOutperform
8/21/2020Kepler Capital MarketsReiterated RatingBuy
8/14/2020Morgan StanleyReiterated RatingOverweight
6/29/2020Kepler Capital MarketsReiterated RatingBuy
6/17/2020Morgan StanleyReiterated RatingOverweight
6/16/2020Kepler Capital MarketsUpgradeBuy
5/27/2020Kepler Capital MarketsReiterated RatingBuy
4/24/2020BarclaysReiterated RatingEqual Weight
4/7/2020Morgan StanleyReiterated RatingOverweight
4/7/2020Kepler Capital MarketsReiterated RatingBuy
9/6/2019Jefferies Financial GroupUpgradeHold ➝ Buy
(Data available from 3/26/2018 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 3 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 3 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Glanbia logo
Glanbia Plc engages in the manufacture and distribution of dairy and nutritional ingredients. It operates through the following segments: Glanbia Performance Nutrition, Glanbia Nutritionals, Glanbia Ireland, and All Other. The Glanbia Performance Nutrition segment manufactures and sells performance nutrition products. The Glanbia Nutritionals segment manufactures and sells cheese, dairy and non-dairy nutritional ingredients. The Glanbia Ireland segment manufactures and sells cheese and dairy ingredients, and a range of consumer products from farm inputs. The All other segment includes both the results of other equity accounted investees who manufacture and sell cheese and dairy ingredients and unallocated corporate costs. The company was founded in 1997 and is headquartered in Kilkenny, Ireland.
Read More

Today's Range

Now: $14.50
Low: $14.50
High: $14.50

50 Day Range

MA: $12.86
Low: $12.08
High: $14.50

52 Week Range

Now: $14.50
Low: $10.80
High: $14.50

Volume

N/A

Average Volume

3,129 shs

Market Capitalization

N/A

P/E Ratio

28.08

Dividend Yield

0.87%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Glanbia?

The following Wall Street research analysts have issued research reports on Glanbia in the last year: Barclays PLC, Berenberg Bank, Credit Suisse Group AG, and Morgan Stanley.
View the latest analyst ratings for GLAPF.

What is the current price target for Glanbia?

2 Wall Street analysts have set twelve-month price targets for Glanbia in the last year. Their average twelve-month price target is $15.60, suggesting a possible upside of 7.6%. Barclays PLC has the highest price target set, predicting GLAPF will reach $17.20 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of $14.00 for Glanbia in the next year.
View the latest price targets for GLAPF.

What is the current consensus analyst rating for Glanbia?

Glanbia currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in GLAPF, but not buy more shares or sell existing shares.
View the latest ratings for GLAPF.

What other companies compete with Glanbia?

Other companies that are similar to Glanbia include AAK AB (publ.), Aryzta, Brunello Cucinelli, Budweiser Brewing Company APAC and China Fruits. Learn More about companies similar to Glanbia.

How do I contact Glanbia's investor relations team?

Glanbia's physical mailing address is Glanbia House, , . The company's listed phone number is 353567772200. The official website for Glanbia is www.glanbia.com. Learn More about contacing Glanbia investor relations.